Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1994

Inghirami G, Lederman S, Yellin MJ, Chadburn A, Chess L, Knowles DM. Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood. 1994;84(3):866-72.

Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis RA. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol. 1994;25(10):1050-6.

Magro CM, Crowson AN. Eosinophilic pustular follicular reaction: a paradigm of immune dysregulation. Int J Dermatol. 1994;33(3):172-8.

Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, et al. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol. 1994;152(5):2163-71.

Tyler JK, Allen KE, Everett RD. Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein. Nucleic Acids Res. 1994;22(3):270-8.

Qin L, Chavin KD, Ding Y, Woodward JE, Favaro JP, Lin J, et al. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1. Ann Surg. 1994;220(4):508-18; discussion 518-9.

Fryer JP, Leventhal JR, Dalmasso AP, Chen S, Simone PA, Jessurun J, et al. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: analysis using adoptive and passive transfer. Transpl Immunol. 1994;2(2):87-93.

Natkunam Y, Zhang X, Liu Z, Chen-Kiang S. Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6. J Immunol. 1994;153(8):3476-84.

Matsushima AY, Cesarman E, Chadburn A, Knowles DM. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol. 1994;144(3):573-84.

McCaffrey TA, Falcone DJ, Vicente D, Du B, Consigli S, Borth W. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan. J Cell Physiol. 1994;159(1):51-9.